HDR-EfficientNet: A Classification of Hypertensive and Diabetic Retinopathy Using Optimize EfficientNet Architecture.

Hypertensive retinopathy (HR) and diabetic retinopathy (DR) are retinal diseases closely associated with high blood pressure. The severity and duration of hypertension directly impact the prevalence of HR. The early identification and assessment of HR are crucial to preventing blindness. Currently, limited computer-aided methods are available for detecting HR and DR. These existing systems rely on traditional machine learning approaches, which require complex image processing techniques and are often limited in their application. To address this challenge, this work introduces a deep learning (DL) method called HDR-EfficientNet, which aims to provide an efficient and accurate approach to identifying various eye-related disorders, including diabetes and hypertensive retinopathy. The proposed method utilizes an EfficientNet-V2 network for end-to-end training focused on disease classification. Additionally, a spatial-channel attention method is incorporated into the approach to enhance its ability to identify specific areas of damage and differentiate between different illnesses. The HDR-EfficientNet model is developed using transfer learning, which helps overcome the challenge of imbalanced sample classes and improves the network's generalization. Dense layers are added to the model structure to enhance the feature selection capacity. The performance of the implemented system is evaluated using a large dataset of over 36,000 augmented retinal fundus images. The results demonstrate promising accuracy, with an average area under the curve (AUC) of 0.98, a specificity (SP) of 96%, an accuracy (ACC) of 98%, and a sensitivity (SE) of 95%. These findings indicate the effectiveness of the suggested HDR-EfficientNet classifier in diagnosing HR and DR. In summary, the HDR-EfficientNet method presents a DL-based approach that offers improved accuracy and efficiency for the detection and classification of HR and DR, providing valuable support in diagnosing and managing these eye-related conditions.

Artificial-Intelligence-Based Decision Making for Oral Potentially Malignant Disorder Diagnosis in Internet of Medical Things Environment.

Oral cancer is considered one of the most common cancer types in several counties. Earlier-stage identification is essential for better prognosis, treatment, and survival. To enhance precision medicine, Internet of Medical Things (IoMT) and deep learning (DL) models can be developed for automated oral cancer classification to improve detection rate and decrease cancer-specific mortality. This article focuses on the design of an optimal Inception-Deep Convolution Neural Network for Oral Potentially Malignant Disorder Detection (OIDCNN-OPMDD) technique in the IoMT environment. The presented OIDCNN-OPMDD technique mainly concentrates on identifying and classifying oral cancer by using an IoMT device-based data collection process. In this study, the feature extraction and classification process are performed using the IDCNN model, which integrates the Inception module with DCNN. To enhance the classification performance of the IDCNN model, the moth flame optimization (MFO) technique can be employed. The experimental results of the OIDCNN-OPMDD technique are investigated, and the results are inspected under specific measures. The experimental outcome pointed out the enhanced performance of the OIDCNN-OPMDD model over other DL models.

[Regional classification-guided wavelet Y-Net network for hard exudate segmentation in fundus images].

OBJECTIVE: We propose an hard exudate(EX)segmentation algorithm based on regional classification-guided wavelet Y-Net network to eliminate the influence of optic disc on EX segmentation process. METHODS: The wavelet Y-Net network was an end-to-end fundus image EX segmentation network, which combined the regional detection of optic disc and hard exudates segmentation by regional classification-guided EX segmentation to effectively reduce the interference of optic disc in EX segmentation.To avoid failure of small EX region segmentation caused by information loss due to down-sampling operation, discrete wavelet transform (DWT) and inverse discrete wavelet transform (IDWT) were introduced to replace the traditional pooling down-sampling and up-sampling operations.Meanwhile, the inception module based on residual connection was used to obtain the multi-scale features.The proposed algorithm was trained and tested on the IDRiD and e-ophtha EX datasets and evaluated at the pixel level. RESULTS: For IDRiD and e-ophtha EX datasets, the proposed algorithm achieved accuracy rates of 0.9858 and 0.9938 with AUC values of 0.9880 and 0.9986, respectively. CONCLUSION: The proposed method can effectively avoid the influence of the optic disc, retain the image details, and improve the effect of EX segmentation.

CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.

BACKGROUND: Cancer of unknown primary (CUP), representing approximately 3-5% of all malignancies, is defined as metastatic cancer where a primary site of origin cannot be found despite a standard diagnostic workup. Because knowledge of a patient's primary cancer remains fundamental to their treatment, CUP patients are significantly disadvantaged and most have a poor survival outcome. Developing robust and accessible diagnostic methods for resolving cancer tissue of origin, therefore, has significant value for CUP patients. METHODS: We developed an RNA-based classifier called CUP-AI-Dx that utilizes a 1D Inception convolutional neural network (1D-Inception) model to infer a tumor's primary tissue of origin. CUP-AI-Dx was trained using the transcriptional profiles of 18,217 primary tumours representing 32 cancer types from The Cancer Genome Atlas project (TCGA) and International Cancer Genome Consortium (ICGC). Gene expression data was ordered by gene chromosomal coordinates as input to the 1D-CNN model, and the model utilizes multiple convolutional kernels with different configurations simultaneously to improve generality. The model was optimized through extensive hyperparameter tuning, including different max-pooling layers and dropout settings. For 11 tumour types, we also developed a random forest model that can classify the tumour's molecular subtype according to prior TCGA studies. The optimised CUP-AI-Dx tissue of origin classifier was tested on 394 metastatic samples from 11 tumour types from TCGA and 92 formalin-fixed paraffin-embedded (FFPE) samples representing 18 cancer types from two clinical laboratories. The CUP-AI-Dx molecular subtype was also independently tested on independent ovarian and breast cancer microarray datasets FINDINGS: CUP-AI-Dx identifies the primary site with an overall top-1-accuracy of 98.54% in cross-validation and 96.70% on a test dataset. When applied to two independent clinical-grade RNA-seq datasets generated from two different institutes from the US and Australia, our model predicted the primary site with a top-1-accuracy of 86.96% and 72.46% respectively. INTERPRETATION: The CUP-AI-Dx predicts tumour primary site and molecular subtype with high accuracy and therefore can be used to assist the diagnostic work-up of cancers of unknown primary or uncertain origin using a common and accessible genomics platform. FUNDING: NIH R35 GM133562, NCI P30 CA034196, Victorian Cancer Agency Australia.